A fixed cutoff of OD 0.2 at 492 nm defines a positive result in the standard sandwich ELISA for viral antigen detection in fluid samples. The procedure uses a capture antibody-coated 96-well plate, samples tested neat and at 1/2 dilution, an HRP-conjugated detection antibody, and OPD substrate development. A result is considered positive if the optical density is ≥ 0.2, provided all control ODs exceed this threshold.
The gold-standard protocol for viral antigen sandwich ELISA involves a sequence of coating, blocking, sample incubation, detection conjugation, and colorimetric substrate development read at 492 nm. The binary cutoff of OD 0.2—validated by controls—provides a clear, semi-quantitative positive/negative call that underpins diagnostic screening and assay quality control.
The Standardized 96-Well Sandwich ELISA Procedure
Plate Coating and Preparation
The foundation of the assay is the capture antibody, typically a monoclonal antibody specific to the target viral antigen. The antibody is diluted in an appropriate coating buffer and immobilized onto the wells of a 96-well microplate. Incubation overnight at 4°C allows passive adsorption, creating a high-density antigen-capture surface.
Washing and Blocking Steps
After coating, unbound capture antibody must be removed to reduce background. The plate is washed three times with PBS-Tween 20 (0.05%), using 150–200 µL per well and a 3-minute soak per wash. While the primary reference doesn't explicitly describe a blocking step, standard practice often includes a protein blocking buffer after coating to minimize non-specific binding. If omitted, the stringent wash steps help compensate.
Sample Incubation and Layout
Test samples (e.g., swab eluates or cell culture supernatants) are added at 50 µL per well. A critical detail is that each sample is run in duplicate, both undiluted and at a 1/2 dilution. This dilution strategy helps detect a prozone (hook) effect and provides a rudimentary titer estimate. Positive and negative controls must be included on every plate. Incubation is performed for exactly 1 hour at 37°C to drive antigen-antibody binding to equilibrium.
Detection and Signal Generation
After washing three times to remove unbound antigen, a HRP-conjugated monoclonal detection antibody is added (50 µL/well). This forms the sandwich: capture antibody–antigen–detection antibody-HRP. After a second 1-hour incubation at 37°C and a final wash, the substrate OPD (o-phenylenediamine) is distributed.
The OPD working solution is freshly prepared at 0.5 mg/mL in phosphate-citrate buffer (pH 5.0) containing 0.02% hydrogen peroxide. The plate incubates for 10 minutes at room temperature in the dark. The reaction is then stopped by adding 50 µL/well of 2N sulfuric acid, and the absorbance is read immediately at 492 nm.
The OD 0.2 Cutoff: How to Interpret Results
Control Validation Comes First
Before any sample can be called positive, you must verify that the positive control has an OD greater than 0.2. If the positive control fails, the entire plate is invalid—reagents may have degraded, incubation temperatures may have drifted, or the wash steps were inadequate. The negative control should ideally read well below 0.2, confirming low background.
The Positive/Negative Threshold
The cutoff is an absolute OD of 0.2. Samples giving OD ≥ 0.2 are called positive; those < 0.2 are negative. This simple rule works well for high-titer viral antigens but can be limiting with borderline samples. Because the reading is monochromatic and endpoint only, no standard curve is required for a qualitative call.
The Role of Duplicate Dilutions
Testing both neat and 1:2 samples provides an internal check. A true positive will typically show a drop in OD upon dilution, while a false positive from non-specific binding might remain unchanged. If the neat sample is above the cutoff but the 1:2 sample falls below, it can indicate a low-level true positive or a borderline non-specific signal, warranting repeat testing or confirmation by another method.
Understanding the Trade-offs
The Limits of a Fixed Cutoff
A universal cutoff of 0.2 OD is robust but not perfect. It assumes every plate, reagent lot, and sample matrix behaves identically. In reality, day-to-day plate variability can shift the background, causing slight changes in negative sample OD. A sample reading 0.21 might be falsely called positive, while a 0.19 might be missed. True clinical assay validation often defines the cutoff statistically by analyzing a panel of known negative samples (e.g., mean negative OD plus 3 standard deviations), which may differ from the 0.2 benchmark.
Impact of Sample Quality and Matrix
Fluid samples like nasal washes or cell culture media contain proteins, lipids, and other interferents that can increase background or inhibit HRP activity. The 1/2 dilution helps mitigate some of these effects, but heavily viscous or contaminated samples may still produce anomalous readings. This protocol does not include detergents or protein stabilizers beyond the PBS-Tween wash buffer, so pre-analytical sample handling is critical.
The Dangers of Over-Interpretation
An OD of 0.2 is a qualitative threshold, not a quantitative concentration. Many users mistakenly treat higher OD values as a direct measure of viral load. Because the signal plateaus as substrate depletes and antigen saturates binding sites, OD values far above 1.0 often reside in the non-linear range. For approximate quantification, a standard curve of known antigen concentrations must be run on the same plate.
Why Validation Controls Are Non-Negotiable
Running the assay without a positive control OD above 0.2 voids any result. This cutoff ensures the conjugate remains active and the substrate develops properly. If the positive control is only borderline (e.g., 0.21), the entire plate may be on the edge of detection sensitivity, and results should be treated with extreme caution or repeated.
Making the Right Choice for Your Goal
The standard sandwich ELISA protocol with a 0.2 OD cutoff is a workhorse for initial screening and quality control. How you deploy it depends on your ultimate question.
- If your primary focus is rapid screening for high viral loads: This direct, binary cutoff is ideal. Run samples neat and at 1/2, and call positives based on the 0.2 threshold after confirming controls. It delivers fast, actionable yes/no answers.
- If your primary focus is research-level quantification: Do not rely on the 0.2 cutoff alone. Run a standard curve of purified or inactivated antigen and calculate sample concentrations from OD. Use the cutoff only to define the limit of detection for your curve.
- If your primary focus is diagnostic validation on clinical samples: Establish your own cutoff statistically from a panel of true negatives. The 0.2 threshold is a benchmark, but your laboratory must confirm that it yields acceptable sensitivity and specificity in your specific population and sample type before adopting it.
Mastering this protocol means understanding both its operational precision and its interpretive boundaries. When you validate your controls, use the 0.2 cutoff as a clear decision point, and resist the urge to over-interpret the numbers, you’ll extract the full diagnostic power of the sandwich ELISA.
Summary Table:
| Assay Step | Parameters & Reagents | Key Purpose / Evaluation |
|---|---|---|
| Plate Coating | Monoclonal capture mAb, 4°C overnight | Immobilizes target-specific capture antibody |
| Washing | 0.05% PBS-Tween 20 (3x, 150–200 µL/well) | Removes unbound reagents and reduces background |
| Sample Incubation | 50 µL/well (neat & 1/2 dilution), 1h at 37°C | Binds antigen; duplicate dilutions check for prozone effect |
| Detection & Development | HRP-conjugated mAb + OPD substrate, 10 min dark | Generates colorimetric signal read at 492 nm |
| Cutoff Evaluation | Absolute cutoff of OD ≥ 0.2 | Binary positive call (valid only if positive control OD > 0.2) |
Developing sensitive and robust immunoassay protocols requires high-specificity reagents and expert technical validation. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. Accelerate your assay development and optimize ELISA performance by contacting our technical team today.